Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
business development
Biotech
J&J hooks Proteologix for at least $850M in cash
J&J's proposed purchase is the pharma's second biotech buy of the year after scooping up Ambrx.
Max Bayer
May 16, 2024 10:12am
Geopolitics threatens Chinese biotechs' hot out-licensing biz
Apr 11, 2024 4:00am
Equillium delivers new lupus data to Ono's doorstep
Apr 1, 2024 10:53am
Biogen's top dealmaker is keen on rare disease meds
Mar 5, 2024 10:20am
Astellas bets more than $800M on Kelonia's delivery tech
Feb 15, 2024 6:30pm
J&J sees ‘opportunities’ in neuro and immunology post-Ambrx buy
Jan 23, 2024 10:54am